Skip to main content
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan
· Delayed Price · Currency is PKR
Full Chart
Watchlist
Alerts
Compare
368.67
-8.57 (-2.27%)
At close: Jun 19, 2026
Overview
Financials
Forecast
Statistics
Dividends
History
Profile
Chart
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Quarterly
TTM
GlaxoSmithKline Pakistan Ratios and Metrics
Market cap in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Current
Mil
Millions
PKR
PKR
More
Full Width
Fiscal Year
Current
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Jun '26
Jun 18, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Market Capitalization
117,409
124,132
126,403
26,430
27,952
43,474
Market Cap Growth
-2.38%
-1.80%
378.26%
-5.45%
-35.70%
-28.84%
Enterprise Value
107,855
117,492
119,878
22,631
20,591
38,013
Last Close Price
368.67
377.55
371.49
77.67
82.15
121.41
PE Ratio
11.17
12.38
19.34
49.50
11.35
8.12
PS Ratio
1.74
1.88
2.07
0.53
0.67
1.19
PB Ratio
3.24
3.69
4.47
1.22
1.33
2.07
P/TBV Ratio
3.32
3.79
4.63
1.28
1.39
2.17
P/FCF Ratio
15.14
20.41
55.38
112.68
-
11.80
P/OCF Ratio
11.50
14.33
24.99
14.03
-
8.72
EV/Sales Ratio
1.60
1.78
1.96
0.46
0.49
1.04
EV/EBITDA Ratio
5.84
6.64
10.57
7.85
3.48
4.98
EV/EBIT Ratio
6.33
7.18
11.69
11.52
4.06
5.53
EV/FCF Ratio
13.91
19.32
52.52
96.49
-
10.32
Debt / Equity Ratio
0.01
0.02
0.01
0.03
0.02
0.01
Debt / EBITDA Ratio
0.02
0.03
0.03
0.25
0.06
0.04
Debt / FCF Ratio
0.05
0.10
0.16
3.09
-
0.08
Net Debt / Equity Ratio
-0.26
-0.24
-0.22
-0.13
-0.21
-0.40
Net Debt / EBITDA Ratio
-0.52
-0.45
-0.54
-1.00
-0.75
-1.10
Net Debt / FCF Ratio
-1.23
-1.31
-2.69
-12.30
0.94
-2.29
Asset Turnover
1.31
1.38
1.47
1.35
1.27
1.30
Inventory Turnover
3.11
3.40
3.95
4.30
4.20
4.24
Quick Ratio
1.44
1.35
1.17
0.83
0.92
1.41
Current Ratio
2.43
2.32
2.06
1.74
1.82
2.28
Return on Equity (ROE)
31.52%
32.37%
26.17%
2.50%
11.72%
27.84%
Return on Assets (ROA)
20.72%
21.36%
15.40%
3.33%
9.60%
15.20%
Return on Invested Capital (ROIC)
39.12%
41.11%
31.26%
2.72%
16.74%
40.71%
Return on Capital Employed (ROCE)
44.70%
46.00%
34.00%
8.30%
22.40%
31.10%
Earnings Yield
8.95%
8.08%
5.17%
2.02%
8.81%
12.32%
FCF Yield
6.61%
4.90%
1.81%
0.89%
-16.79%
8.47%
Dividend Yield
4.61%
4.50%
2.69%
-
-
5.77%
Payout Ratio
45.13%
47.30%
0.03%
345.56%
15.23%
38.51%
Total Shareholder Return
4.61%
4.50%
2.69%
-
-
5.77%